Later stronger years need not erase the earlier gap.
Years 1–5: broad 6%, tilt 2% annually.
Years 6–10: broad 4%, tilt 7% annually.
- Year 0
- Broad €10,000.00
Tilted €10,000.00 - Year 5
- Broad €13,382.26
Tilted €11,040.81 - Year 10
- Broad €16,281.56
Tilted €15,485.30
Lines connect the three checkpoints; they do not show intervening price movements. Scale starts at €0.
Which balance earns the later 7%? The tilt starts that stage €2,341.45 behind. Both make a nominal gain; the gap shrinks to €796.26 but does not disappear.
A real tilt can lose, keep lagging or finish ahead; a long horizon supplies no premium deadline.
Follow both five-year stages using unrounded amounts
After five years: €10,000 × 1.06⁵ = €13,382.255776; €10,000 × 1.02⁵ = €11,040.808032.
Next: multiply those unrounded amounts by 1.04⁵ and 1.07⁵ respectively. Adding annual percentage-point gaps misses the unequal bases.
MSCI describes prolonged underperformance: no maximum waiting period or guaranteed recovery of relative losses.
Can you maintain the choice without monthly reassurance?
Lagging friends can hurt while the account grows. Needing an optimistic explanation each month or daily commentary can exceed your intended attention budget.
FINRA separates willingness and capacity: tolerating lag does not fund a bill, and financial capacity does not ensure a tolerable experience. A smaller tilt changes exposure without imposing a maximum loss or establishing a suitable size. Borrowing adds risk rather than resolving uncertainty about the premium.
The bill cannot wait for relative recovery.
Use actual available capital in the spending currency and on time. An assumed extra premium cannot fund an otherwise unaffordable goal.
Switching to broad shares changes exposure while retaining substantial share-market risk. As Vanguard’s goal-first approach implies, review the whole funding arrangement; choosing the other share strategy does not secure a fixed payment.
Did implementation fail, or did the rule disappoint?
Retain the rationale; review methodology, costs, access, evidence and household changes using consistent currency, income treatment and universe. Patience need not mean indefinite holding.
Changed terms and multi-factor proposals
Changed methodology or expensive execution can warrant action even when earlier research remains credible. Hagstrom’s process/outcome distinction allows a process to become unconvincing; recent returns alone settle neither question.
More factor labels can share holdings/risks. Combining them creates another policy requiring evidence and implementation checks, not protection against its next weak period.
Simplifying needs a reason, not proof of zero premium.
Evidence and burden can justify declining a tilt without proving its future premium exactly zero. For an existing position, assess transaction costs, tax and resulting exposure.
Record a reason that remains recognisable if the abandoned factor later wins. Chasing the latest winner instead commits you to predicting the next; it does not resolve the original uncertainty.